Most Read News

The Board of Godrej Industries at its meeting held on 14 November 2022 has approved the increase in borrowing powers of the company from Rs 4500 crore to Rs 6500 crore over and above the paid-up capital free reserves and securities premium of the company subject to approval of the shareholders of the company

Tide Water Oil Company India announced that the Board of Directors of the Company at its meeting held on 14 November 2022 has recommended a Second Interim dividend of Rs12 per share ie600Percentage subject to the approval of the shareholders

Steel Authority of India announced the cessation of Nidgurti Shankarappa as Non Official Independent Director on board of the company with effect from 13 November 2022 on completion of his tenure

Alan Scott Industries will hold a meeting of the Board of Directors of the Company on 18 November 2022

Debock Industries will hold a meeting of the Board of Directors of the Company on 16 November 2022

Hindustan Unilever Limited has informed the Exchange about Investor Presentation

Voltas has entered into a Technology License Agreement to develop manufacture sell and service medical refrigeration and vaccine storage equipment including Ice lined Refrigerators Vaccine Freezers and Ultra low temperature Freezers to the India market Vestfrost Solutions founded in Esbjerg Denmark in 1963 is one of the global developers and manufacturers of innovative and efficient refrigerators and freezers in the Bio Medical and Cold Chain […]

The Board of Indo Cotspin will meet on 30 November 2022 to consider the proposal for sub-division of the equity shares of the company having a face value of Rs 10 each and alteration of authorised share capital clause of the company

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 23 November 2022

Stelis Biopharma the biologics arm of Strides Pharma Science announced that its product division Biolexis has a major success with its first biosimilar product Kauliv receiving a positive recommendation from European Medicines Agency EMA for granting of market authorization Kauliv is a recombinant human teriparatide injection intended for the treatment of osteoporosis The Company informed that EMAs Committee for Medicinal Products for Human Use CHMP […]